The ongoing need for a
broad spectrum
anti viral
Viral infections are a major and continuing global healthcare threat. Respiratory viral infections have reached epidemic and pandemic magnitude, and there is clear need for novel antiviral agents.
Deadly viral diseases such as influenza, HIV, AIDS, Zika virus, dengue and SARS-CoV-2 have emerged and their spread globally has become faster and more dangerous.
In the fight against these viruses, there is a clear need for effective antiviral therapeutics in addition to vaccines.
